Emma Walmsley upholds £40B sales target in her final GSK CEO report Emma Walmsley and her GSK CEO successor, Luke Miels, are safeguarding the British pharma’s 40 billion-pound-sterling sales projection for 2031 on the back of a strong quarter. | Emma Walmsley and her ...

#GSK #EmmaWalmsley #LukeMiels #Blenrep #Arexvy #Shingrix #multiplemyeloma #PD1inhibitor #Jemperli #rectalcancer #antibodydrugconjugates #ADCs #HansohPharma #FDAapproval #longactingbiologic #depemokima #chronicrhinosinusitis #biologics #vaccines #shinglesvaccine #RSVvaccine
zurl.co/iumHW

Walmsley to leave GSK in surprise exit This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years to be replaced by Luke Miels.

This week has kicked off with the unexpected news that #EmmaWalmsley is standing down as chief executive of #GSK after eight years, to be replaced by current chief commercial officer #LukeMiels.

pharmaphorum.com/news/walmsle...

Who is Luke Miels? Meet the New GSK CEO Replacing Emma Walmsley Luke Miels, GSK’s Chief Commercial Officer, will replace Emma Walmsley as CEO on January 1, 2026. Learn about his career, role in oncology and vaccines, and what his leadership means for GSK’s future.

Who is Luke Miels? Meet the New GSK CEO Replacing Emma Walmsley
#LukeMiels #GSK #PharmaNews #EmmaWalmsley #Healthcare #Biotech #Oncology #Vaccines #Leadership #BreakingNews
gtvnewshd.com/biography/20...